In this episode of Top Biotechs at ASCO, Ruthie Davi, Senior Vice President at Medidata Solutions, shares how historical clinical trial data and AI-powered tools are reshaping cancer research and trial design.
- New analysis on platinum-resistant ovarian cancer post-PARP inhibitors
- Real-world applications of AI in oncology, including HER2-low detection and activity monitoring
- Introduction to Protocol Optimizer, a simulation tool for optimizing trial design before execution
- How Medidata’s data-sharing program leverages Rave to generate actionable insights across trials
- Use of historical data to build external control arms and improve efficiency in severe disease trials
From enhancing protocol efficiency to enabling patient-centric innovation, this conversation offers a glimpse into the future of oncology research powered by data and technology.